ProPhase Labs, Inc.
PRPH
$0.02
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 111.51% | -39.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 111.51% | -39.03% | |||
| Cost of Revenue | 152.41% | -42.09% | |||
| Gross Profit | 35.33% | -32.39% | |||
| SG&A Expenses | 3.57% | -53.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.59% | -52.64% | |||
| Operating Income | -1.54% | 54.51% | |||
| Income Before Tax | 23.64% | 50.37% | |||
| Income Tax Expenses | -99.13% | 320.90% | |||
| Earnings from Continuing Operations | 43.01% | 27.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 43.01% | 27.63% | |||
| EBIT | -1.54% | 54.51% | |||
| EBITDA | -2.37% | 65.50% | |||
| EPS Basic | 49.92% | -29.96% | |||
| Normalized Basic EPS | 18.54% | 28.14% | |||
| EPS Diluted | 49.39% | -29.96% | |||
| Normalized Diluted EPS | 18.54% | 28.14% | |||
| Average Basic Shares Outstanding | 13.79% | -44.31% | |||
| Average Diluted Shares Outstanding | 13.79% | -44.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||